Literature DB >> 112062

Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense.

M J Chusid, S D Davis.   

Abstract

Quantitative techniques were used to determine the relative concentrations of viable bacteria and polymorphonuclear leukocytes (PMNs) in the corneas of neutropenic and non-neutropenic guinea pigs with experimental bacterial keratitis induced with three strains of Pseudomonas aeruginosa. Neutropenia was produced by whole-body X-irradiation 1 week before infection. Significantly greater numbers of bacteria were present in the cornea of neutropenic animals 48 h after infection than were present in the corneas of non-neutropenic animals. The same was true 24 and 48 h after infecting animals with Staphylococcus aureus. Examination of histological sections showed that fewer PMNs were present in the corneas of infected neutropenic animals than in the corneas of infected non-neutropenic animals. Radiolabeling of PMNs confirmed a significant reduction in PMN concentration in the corneas of infected neutropenic animals. Tears and the corneal epithelium appear to be the most important elements protecting the cornea against local invasion by bacteria. However, once bacterial keratitis is established, PMNs play a role in limiting bacterial multiplication.

Entities:  

Mesh:

Year:  1979        PMID: 112062      PMCID: PMC414399          DOI: 10.1128/iai.24.3.948-952.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Corneal infections after cortisone therapy.

Authors:  Y MITSUI; J HANABUSA
Journal:  Br J Ophthalmol       Date:  1955-04       Impact factor: 4.638

2.  Corneal wound healing. I. The movement of polymorphonuclear leukocytes into corneal wounds.

Authors:  R M ROBB; T KUWABARA
Journal:  Arch Ophthalmol       Date:  1962-11

3.  Corneal collagenolytic activity in rabbit polymorphonuclear leukocytes.

Authors:  J J Rowsey; R M Nisbet; J L Swedo; L Katona
Journal:  J Ultrastruct Res       Date:  1976-10

4.  Electron microscopic studies of graft endothelium in corneal graft rejection.

Authors:  F M Polack; A Kanai
Journal:  Am J Ophthalmol       Date:  1972-05       Impact factor: 5.258

5.  Quantitation of inflammation in the cornea.

Authors:  H M Leibowitz; J H Lass; A Kupferman
Journal:  Arch Ophthalmol       Date:  1974-11

Review 6.  Management of pseudomonas keratitis.

Authors:  P C Hessburg
Journal:  Surv Ophthalmol       Date:  1969-07       Impact factor: 6.048

7.  Non-lysozyme antibacterial factor in human tears.

Authors:  B R Friedland; D R Anderson; R K Forster
Journal:  Am J Ophthalmol       Date:  1972-07       Impact factor: 5.258

8.  Pathogenesis of experimental Pseudomonas keratitis in the guinea pig: bacteriologic, clinical, and microscopic observations.

Authors:  D L Van Horn; S D Davis; R A Hyndiuk; T V Alpren
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-11       Impact factor: 4.799

9.  Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.

Authors:  S D Davis; L D Sarff; R A Hyndiuk
Journal:  Arch Ophthalmol       Date:  1977-09

10.  Migration of transfused granulocytes in leukopenic dogs.

Authors:  F R Appelbaum; L Norton; R G Graw
Journal:  Blood       Date:  1977-03       Impact factor: 22.113

View more
  15 in total

1.  The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits.

Authors:  N Duran; A Koc; H Oksuz; C Tamer; Y Akaydin; T Kozlu; M Celik
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

Authors:  Sharon McClellan; Xiaoyu Jiang; Ronald Barrett; Linda D Hazlett
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

Review 3.  Experimental Pseudomonas keratitis.

Authors:  R A Hyndiuk
Journal:  Trans Am Ophthalmol Soc       Date:  1981

4.  Spontaneous bacterial keratitis in CD36 knockout mice.

Authors:  Julia Klocke; Rita N Barcia; Susan Heimer; Elke Cario; James Zieske; Michael S Gilmore; Bruce R Ksander; Meredith S Gregory
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

5.  Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa.

Authors:  M J Preston; K A Kernacki; J M Berk; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion.

Authors:  Ashok Kumar; Jing Zhang; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

7.  Antimicrobial efficacy and ocular cell toxicity from silver nanoparticles.

Authors:  Colleen M Santoro; Nicole L Duchsherer; David W Grainger
Journal:  Nanobiotechnology       Date:  2007-05-01

8.  Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.

Authors:  Tanweer S Zaidi; Tauqeer Zaidi; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-05       Impact factor: 4.799

9.  Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.

Authors:  M J Preston; J M Berk; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

10.  Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.

Authors:  Joseph J Dajcs; Brett A Thibodeaux; Mary E Marquart; Dalia O Girgis; Mullika Traidej; Richard J O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.